204 related articles for article (PubMed ID: 38690580)
1. Metabolism-dependent secondary effect of anti-MAPK cancer therapy on DNA repair.
Aubé F; Fontrodona N; Guiguettaz L; Vallin E; Fabbri L; Lapendry A; Vagner S; Ricci EP; Auboeuf D
NAR Cancer; 2024 Jun; 6(2):zcae019. PubMed ID: 38690580
[TBL] [Abstract][Full Text] [Related]
2. A Fatty Acid Oxidation-dependent Metabolic Shift Regulates the Adaptation of
Aloia A; Müllhaupt D; Chabbert CD; Eberhart T; Flückiger-Mangual S; Vukolic A; Eichhoff O; Irmisch A; Alexander LT; Scibona E; Frederick DT; Miao B; Tian T; Cheng C; Kwong LN; Wei Z; Sullivan RJ; Boland GM; Herlyn M; Flaherty KT; Zamboni N; Dummer R; Zhang G; Levesque MP; Krek W; Kovacs WJ
Clin Cancer Res; 2019 Nov; 25(22):6852-6867. PubMed ID: 31375515
[TBL] [Abstract][Full Text] [Related]
3. Exploiting Drug Addiction Mechanisms to Select against MAPKi-Resistant Melanoma.
Hong A; Moriceau G; Sun L; Lomeli S; Piva M; Damoiseaux R; Holmen SL; Sharpless NE; Hugo W; Lo RS
Cancer Discov; 2018 Jan; 8(1):74-93. PubMed ID: 28923912
[TBL] [Abstract][Full Text] [Related]
4. Codon optimality controls differential mRNA translation during amino acid starvation.
Saikia M; Wang X; Mao Y; Wan J; Pan T; Qian SB
RNA; 2016 Nov; 22(11):1719-1727. PubMed ID: 27613579
[TBL] [Abstract][Full Text] [Related]
5. Cellular mRNAs access second ORFs using a novel amino acid sequence-dependent coupled translation termination-reinitiation mechanism.
Gould PS; Dyer NP; Croft W; Ott S; Easton AJ
RNA; 2014 Mar; 20(3):373-81. PubMed ID: 24412912
[TBL] [Abstract][Full Text] [Related]
6. On the flexibility of the cellular amination network in
Schulz-Mirbach H; Müller A; Wu T; Pfister P; Aslan S; Schada von Borzyskowski L; Erb TJ; Bar-Even A; Lindner SN
Elife; 2022 Jul; 11():. PubMed ID: 35876664
[TBL] [Abstract][Full Text] [Related]
7. Sustained compensatory p38 MAPK signaling following treatment with MAPK inhibitors induces the immunosuppressive protein CD73 in cancer: combined targeting could improve outcomes.
Terp MG; Gammelgaard OL; Vever H; Gjerstorff MF; Ditzel HJ
Mol Oncol; 2021 Dec; 15(12):3299-3316. PubMed ID: 34165921
[TBL] [Abstract][Full Text] [Related]
8. Translation termination is involved in histone mRNA degradation when DNA replication is inhibited.
Kaygun H; Marzluff WF
Mol Cell Biol; 2005 Aug; 25(16):6879-88. PubMed ID: 16055702
[TBL] [Abstract][Full Text] [Related]
9. Targeting mitochondrial biogenesis to overcome drug resistance to MAPK inhibitors.
Zhang G; Frederick DT; Wu L; Wei Z; Krepler C; Srinivasan S; Chae YC; Xu X; Choi H; Dimwamwa E; Ope O; Shannan B; Basu D; Zhang D; Guha M; Xiao M; Randell S; Sproesser K; Xu W; Liu J; Karakousis GC; Schuchter LM; Gangadhar TC; Amaravadi RK; Gu M; Xu C; Ghosh A; Xu W; Tian T; Zhang J; Zha S; Liu Q; Brafford P; Weeraratna A; Davies MA; Wargo JA; Avadhani NG; Lu Y; Mills GB; Altieri DC; Flaherty KT; Herlyn M
J Clin Invest; 2016 May; 126(5):1834-56. PubMed ID: 27043285
[TBL] [Abstract][Full Text] [Related]
10. Role of dual specificity phosphatases (DUSPs) in melanoma cellular plasticity and drug resistance.
Singh MK; Altameemi S; Lares M; Newton MA; Setaluri V
Sci Rep; 2022 Aug; 12(1):14395. PubMed ID: 35999349
[TBL] [Abstract][Full Text] [Related]
11. Notch signaling activation induces cell death in MAPKi-resistant melanoma cells.
Mikheil DM; Prabhakar K; Arshad A; Rodriguez CI; Newton MA; Setaluri V
Pigment Cell Melanoma Res; 2019 Jul; 32(4):528-539. PubMed ID: 30614626
[TBL] [Abstract][Full Text] [Related]
12. Enhancing PD-L1 Degradation by ITCH during MAPK Inhibitor Therapy Suppresses Acquired Resistance.
Yang Z; Wang Y; Liu S; Deng W; Lomeli SH; Moriceau G; Wohlschlegel J; Piva M; Lo RS
Cancer Discov; 2022 Aug; 12(8):1942-1959. PubMed ID: 35638972
[TBL] [Abstract][Full Text] [Related]
13. The Origin of Prebiotic Information System in the Peptide/RNA World: A Simulation Model of the Evolution of Translation and the Genetic Code.
Chatterjee S; Yadav S
Life (Basel); 2019 Mar; 9(1):. PubMed ID: 30832272
[TBL] [Abstract][Full Text] [Related]
14. Co-expression of TNF receptors 1 and 2 on melanomas facilitates soluble TNF-induced resistance to MAPK pathway inhibitors.
Sander CA; Rush EA; Shi J; Arantes LMRB; Tesi RJ; Ross MA; Calderon MJ; Watkins SC; Kirkwood JM; Ferris RL; Butterfield LH; Vujanovic L
J Transl Med; 2022 Jul; 20(1):331. PubMed ID: 35879777
[TBL] [Abstract][Full Text] [Related]
15. T-type calcium channel inhibition restores sensitivity to MAPK inhibitors in de-differentiated and adaptive melanoma cells.
Granados K; Hüser L; Federico A; Sachindra S; Wolff G; Hielscher T; Novak D; Madrigal-Gamboa V; Sun Q; Vierthaler M; Larribère L; Umansky V; Utikal J
Br J Cancer; 2020 Mar; 122(7):1023-1036. PubMed ID: 32063604
[TBL] [Abstract][Full Text] [Related]
16. Recurrent Tumor Cell-Intrinsic and -Extrinsic Alterations during MAPKi-Induced Melanoma Regression and Early Adaptation.
Song C; Piva M; Sun L; Hong A; Moriceau G; Kong X; Zhang H; Lomeli S; Qian J; Yu CC; Damoiseaux R; Kelley MC; Dahlman KB; Scumpia PO; Sosman JA; Johnson DB; Ribas A; Hugo W; Lo RS
Cancer Discov; 2017 Nov; 7(11):1248-1265. PubMed ID: 28864476
[TBL] [Abstract][Full Text] [Related]
17. siRNA knock down of glutamate dehydrogenase in astrocytes affects glutamate metabolism leading to extensive accumulation of the neuroactive amino acids glutamate and aspartate.
Skytt DM; Klawonn AM; Stridh MH; Pajęcka K; Patruss Y; Quintana-Cabrera R; Bolaños JP; Schousboe A; Waagepetersen HS
Neurochem Int; 2012 Sep; 61(4):490-7. PubMed ID: 22542772
[TBL] [Abstract][Full Text] [Related]
18. Intracellular acidification of the leech giant glial cell evoked by glutamate and aspartate.
Deitmer JW; Schneider HP
Glia; 1997 Feb; 19(2):111-22. PubMed ID: 9034828
[TBL] [Abstract][Full Text] [Related]
19. DNA Damage, Repair, and Cancer Metabolism.
Turgeon MO; Perry NJS; Poulogiannis G
Front Oncol; 2018; 8():15. PubMed ID: 29459886
[TBL] [Abstract][Full Text] [Related]
20. Oxidation of amino acids, glucose, and fatty acids as metabolic fuels in enterocytes of post-hatching developing chickens.
He W; Furukawa K; Bailey CA; Wu G
J Anim Sci; 2022 Apr; 100(4):. PubMed ID: 35199826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
